Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Other financing activities (2016 - 2025)

Historic Other financing activities for Xtant Medical Holdings (XTNT) over the last 11 years, with Q2 2025 value amounting to $15000.0.

  • Xtant Medical Holdings' Other financing activities fell 9162.01% to $15000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $52000.0, marking a year-over-year decrease of 9266.57%. This contributed to the annual value of $651000.0 for FY2024, which is 17238.49% up from last year.
  • Per Xtant Medical Holdings' latest filing, its Other financing activities stood at $15000.0 for Q2 2025, which was down 9162.01% from $34000.0 recorded in Q1 2025.
  • Xtant Medical Holdings' Other financing activities' 5-year high stood at $436000.0 during Q1 2024, with a 5-year trough of $3000.0 in Q4 2024.
  • In the last 4 years, Xtant Medical Holdings' Other financing activities had a median value of $40000.0 in 2023 and averaged $100555.6.
  • In the last 5 years, Xtant Medical Holdings' Other financing activities surged by 99000.0% in 2024 and then tumbled by 9220.18% in 2025.
  • Over the past 4 years, Xtant Medical Holdings' Other financing activities (Quarter) stood at $104000.0 in 2021, then plummeted by 41.35% to $61000.0 in 2023, then tumbled by 95.08% to $3000.0 in 2024, then surged by 400.0% to $15000.0 in 2025.
  • Its last three reported values are $15000.0 in Q2 2025, $34000.0 for Q1 2025, and $3000.0 during Q4 2024.